Search

Your search keyword '"Oduyebo, Titilope"' showing total 246 results
Start Over Author "Oduyebo, Titilope"
246 results on '"Oduyebo, Titilope"'

1. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta

Author

Reagan-Steiner, Sarah, Bhatnagar, Julu, Martines, Roosecelis B., Milligan, Nicholas S., Gisondo, Carly, Williams, Frank B., Lee, Elizabeth, Estetter, Lindsey, Bullock, Hannah, Goldsmith, Cynthia S., Fair, Pamela, Hand, Julie, Richardson, Gillian, Woodworth, Kate R., Oduyebo, Titilope, Galang, Romeo R., Phillips, Rebecca, Belyaeva, Elizaveta, Yin, Xiao-Ming, Meaney-Delman, Dana, Uyeki, Timothy M., Roberts, Drucilla J., and Zaki, Sherif R.

Subjects
Infants -- Patient outcomes, Perinatal infection -- Risk factors -- Complications and side effects -- Case studies, Premature birth -- Case studies, Health
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is associated with severe maternal coronavirus disease (COVID-19) and preterm birth and may increase the risk for other complications of [...]

Published
2022
Full Text
View/download PDF

3. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., and Tong, Van T.

Published
2020

6. Influenza and Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage During Pregnancy: Pregnancy Risk Assessment Monitoring System, 2020.

Author

Kortsmit, Katherine, Oduyebo, Titilope, Simeone, Regina M., Kahn, Katherine E., Razzaghi, Hilda, Galang, Romeo R., Ellington, Sascha, Ruffo, Nan, Barfield, Wanda D., Warner, Lee, and Cox, Shanna

Subjects
*INFLUENZA vaccines, *DPT vaccines, *CONFIDENCE intervals, *VACCINATION coverage, *DESCRIPTIVE statistics, *CHI-squared test, *DISEASE prevalence, *HEALTH equity, *WOMEN'S health, *PREGNANCY
Abstract

Objectives: Estimates of vaccination coverage during pregnancy and identification of disparities in vaccination coverage can inform vaccination campaigns and programs. We reported the prevalence of being offered or told to get the influenza vaccine by a health care provider (hereinafter, provider); influenza vaccination coverage during the 12 months before delivery; and tetanus, diphtheria, and acellular pertussis (Tdap) vaccination coverage during pregnancy among women with a recent live birth in the United States. Methods: We analyzed 2020 data from the Pregnancy Risk Assessment Monitoring System from 42 US jurisdictions (n = 41 673). We estimated the overall prevalence of being offered or told to get the influenza vaccine by a provider and influenza vaccination coverage during the 12 months before delivery. We estimated Tdap vaccination coverage during pregnancy from 21 jurisdictions with available data (n = 22 020) by jurisdiction and select characteristics. Results: In 2020, 84.9% of women reported being offered or told to get the influenza vaccine, and 60.9% received it, ranging from 35.0% in Puerto Rico to 79.7% in Massachusetts. Influenza vaccination coverage was lower among women who were not offered or told to get the influenza vaccine (21.4%) than among women who were offered or told to get the vaccine (68.1%). Overall, 72.7% of women received the Tdap vaccine, ranging from 52.8% in Mississippi to 86.7% in New Hampshire. Influenza and Tdap vaccination coverage varied by all characteristics examined. Conclusions: These results can inform vaccination programs and strategies to address disparities in vaccination coverage during pregnancy and may inform vaccination efforts for other infectious diseases among pregnant women. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Modes of Transmission of Zika Virus

Author

Gregory, Christopher J., Oduyebo, Titilope, Brault, Aaron C., Brooks, John T., Chung, Koo-Whang, Hills, Susan, Kuehnert, Matthew J., Mead, Paul, Meaney-Delman, Dana, Rabe, Ingrid, Staples, Erin, and Petersen, Lyle R.

Published
2017

10. Update : Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States (Including U.S. Territories), July 2017

Author

Oduyebo, Titilope, Polen, Kara D., Walke, Henry T., Reagan-Steiner, Sarah, Lathrop, Eva, Rabe, Ingrid B., Kuhnert-Tallman, Wendi L., Martin, Stacey W., Walker, Allison T., Gregory, Christopher J., Ades, Edwin W., Carroll, Darin S., Rivera, Maria, Perez-Padilla, Janice, Gould, Carolyn, Nemhauser, Jeffrey B., Beard, C. Ben, Harcourt, Jennifer L., Viens, Laura, Johansson, Michael, Ellington, Sascha R., Petersen, Emily, Smith, Laura A., Reichard, Jessica, Munoz-Jordan, Jorge, Beach, Michael J., Rose, Dale A., Barzilay, Ezra, Noonan-Smith, Michelle, Jamieson, Denise J., Zaki, Sherif R., Petersen, Lyle R., Honein, Margaret A., and Meaney-Delman, Dana

Published
2017

11. Evaluation of Placental and Fetal Tissue Specimens for Zika Virus Infection — 50 States and District of Columbia, January–December, 2016

Author

U.S. Zika Pregnancy Registry Collaboration, Zika Virus Response Epidemiology and Surveillance Task Force Pathology Team, Reagan-Steiner, Sarah, Simeone, Regina, Simon, Elizabeth, Bhatnagar, Julu, Oduyebo, Titilope, Free, Rebecca, Denison, Amy M., Rabeneck, Demi B., Ellington, Sascha, Petersen, Emily, Gary, Joy, Hale, Gillian, Keating, M. Kelly, Martines, Roosecelis B., Muehlenbachs, Atis, Ritter, Jana, Lee, Ellen, Davidson, Alexander, Conners, Erin, Scotland, Sarah, Sandhu, Kayleigh, Bingham, Andrea, Kassens, Elizabeth, Smith, Lou, St. George, Kirsten, Ahmad, Nina, Tanner, Mary, Beavers, Suzanne, Miers, Brooke, VanMaldeghem, Kelley, Khan, Sumaiya, Rabe, Ingrid, Gould, Carolyn, Meaney-Delman, Dana, Honein, Margaret A., Shieh, Wun-Ju, Jamieson, Denise J., Fischer, Marc, and Zaki, Sherif R.

Published
2017

12. Vital Signs : Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016

Author

U.S. Zika Pregnancy Registry Collaboration, Reynolds, Megan R., Jones, Abbey M., Petersen, Emily E., Lee, Ellen H., Rice, Marion E., Bingham, Andrea, Ellington, Sascha R., Evert, Nicole, Reagan-Steiner, Sarah, Oduyebo, Titilope, Brown, Catherine M., Martin, Stacey, Ahmad, Nina, Bhatnagar, Julu, Macdonald, Jennifer, Gould, Carolyn, Fine, Anne D., Polen, Kara D., Lake-Burger, Heather, Hillard, Christina L., Hall, Noemi, Yazdy, Mahsa M., Slaughter, Karnesha, Sommer, Jamie N., Adamski, Alys, Raycraft, Meghan, Fleck-Derderian, Shannon, Gupta, Jyoti, Newsome, Kimberly, Baez-Santiago, Madelyn, Slavinski, Sally, White, Jennifer L., Moore, Cynthia A., Shapiro-Mendoza, Carrie K., Petersen, Lyle, Boyle, Coleen, Jamieson, Denise J., Meaney-Delman, Dana, and Honein, Margaret A.

Published
2017

19. Update : Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure — United States, September 2016

Author

Petersen, Emily E., Meaney-Delman, Dana, Neblett-Fanfair, Robyn, Havers, Fiona, Oduyebo, Titilope, Hills, Susan L., Rabe, Ingrid B., Lambert, Amy, Abercrombie, Julia, Martin, Stacey W., Gould, Carolyn V., Oussayef, Nadia, Polen, Kara N.D., Kuehnert, Matthew J., Pillai, Satish K., Petersen, Lyle R., Honein, Margaret A., Jamieson, Denise J., and Brooks, John T.

Published
2016

21. Update : Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States, July 2016

Author

Oduyebo, Titilope, Igbinosa, Irogue, Petersen, Emily E., Polen, Kara N.D., Pillai, Satish K., Ailes, Elizabeth C., Villanueva, Julie M., Newsome, Kim, Fischer, Marc, Gupta, Priya M., Powers, Ann M., Lampe, Margaret, Hills, Susan, Arnold, Kathryn E., Rose, Laura E., Shapiro-Mendoza, Carrie K., Beard, Charles B., Muñoz, Jorge L., Rao, Carol Y., Meaney-Delman, Dana, Jamieson, Denise J., and Honein, Margaret A.

Published
2016

23. Patterns in Zika Virus Testing and Infection, by Report of Symptoms and Pregnancy Status — United States, January 3–March 5, 2016

Author

The Zika Virus Response Epidemiology and Laboratory Team, Dasgupta, Sharoda, Reagan-Steiner, Sarah, Goodenough, Dana, Russell, Kate, Tanner, Mary, Lewis, Lillianne, Petersen, Emily E., Powers, Ann M., Kniss, Krista, Meaney-Delman, Dana, Oduyebo, Titilope, O’Leary, Dan, Chiu, Sophia, Talley, Pamela, Hennessey, Morgan, Hills, Susan, Cohn, Amanda, and Gregory, Christopher

Published
2016

24. Update : Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure — United States, 2016

Author

Petersen, Emily E., Polen, Kara N. D., Meaney-Delman, Dana, Ellington, Sascha R., Oduyebo, Titilope, Cohn, Amanda, Oster, Alexandra M., Russell, Kate, Kawwass, Jennifer F., Karwowski, Mateusz P., Powers, Ann M., Bertolli, Jeanne, Brooks, John T., Kissin, Dmitry, Villanueva, Julie, Muñoz-Jordan, Jorge, Kuehnert, Matthew, Olson, Christine K., Honein, Margaret A., Rivera, Maria, Jamieson, Denise J., and Rasmussen, Sonja A.

Published
2016

26. Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016

Author

Meaney-Delman, Dana, Hills, Susan L., Williams, Charnetta, Galang, Romeo R., Iyengar, Preetha, Hennenfent, Andrew K., Rabe, Ingrid B., Panella, Amanda, Oduyebo, Titilope, Honein, Margaret A., Zaki, Sherif, Lindsey, Nicole, Lehman, Jennifer A., Kwit, Natalie, Bertolli, Jeanne, Ellington, Sascha, Igbinosa, Irogue, Minta, Anna A., Petersen, Emily E., Mead, Paul, Rasmussen, Sonja A., and Jamieson, Denise J.

Published
2016

28. Zika virus RNA replication and persistence in brain and placental tissue

Author

Bhatnagar, Julu, Rabeneck, Demi B., Martines, Roosecelis B., Reagan-Steiner, Sarah, Ermias, Yokabed, Estetter, Lindsey B.C., Suzuki, Tadaki, Ritter, Jana, Keating, M. Kelly, Hale, Gillian, Gary, Joy, Muehlenbachs, Atis, Lambert, Amy, Lanciotti, Robert, Oduyebo, Titilope, Meaney-Delman, Dana, Bolanos, Fernando, Saad, Edgar Alberto Parra, Shieh, Wun-Ju, and Zaki, Sherif R.

Subjects
United States. Centers for Disease Control and Prevention, Brain -- Health aspects, Infants -- Health aspects, Zika virus -- Health aspects, Virus replication -- Health aspects, Genetic disorders -- Health aspects, RNA -- Health aspects, Health
Abstract

Zika virus has recently caused global concern because of an unprecedented outbreak of infection in Brazil and its association with congenital microcephaly and other adverse pregnancy outcomes, including pregnancy loss [...]

Published
2017
Full Text
View/download PDF

32. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy--Eight Integrated Health Care Organizations, United States, December 14, 2020-May 8, 2021

Author

Razzaghi, Hilda, Meghani, Mehreen, Pingali, Cassandra, Crane, Bradley, Naleway, Allison, Weintraub, Eric, Kenigsberg, TatYana A., Lamias, Mark J., Irving, Stephanie A., Kauffman, Tia L., Vesco, Kimberly K., Daley, Matthew F., DeSilva, Malini, Donahue, James, Getahun, Darios, Glenn, Sungching, Hambidge, Simon J., Jackson, Lisa, Lipkind, Heather S., Nelson, Jennifer, Zerbo, Ousseny, Oduyebo, Titilope, Singleton, James A., and Patel, Suchita A.

Subjects
Johnson & Johnson, Pfizer Inc., Tetanus antitoxin, Vaccination, DPT vaccine, Pregnant women, Infants (Premature), Pharmaceutical industry, Health
Abstract

On June 15, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). COVID-19 vaccines are critical for ending the COVID-19 pandemic; however, current data [...]

Published
2021

33. Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy

Author

Honein, Margaret A., Dawson, April L., Petersen, Emily E., Jones, Abbey M., Lee, Ellen H., Yazdy, Mahsa M., Ahmad, Nina, Macdonald, Jennifer, Evert, Nicole, Bingham, Andrea, Ellington, Sascha R., Shapiro-Mendoza, Carrie K., Oduyebo, Titilope, Fine, Anne D., Brown, Catherine M., Sommer, Jamie N., Gupta, Jyoti, Cavicchia, Philip, Slavinski, Sally, White, Jennifer L., Owen, S. Michele, Petersen, Lyle R., Boyle, Coleen, Meaney-Delman, Dana, and Jamieson, Denise J.

Published
2017
Full Text
View/download PDF

34. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., Tong, Van T., Delaney, Augustina, Hsia, Jason, King, Kellianne, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Sancken, Christina, Sims, John, Smoots, Ashley, Snead, Margaret, Strid, Penelope, Yowe-Conley, Tineka, Zambrano, Laura, Zapata, Lauren, Manning, Susan, Burkel, Veronica, Akosa, Amanda, Bennett, Carolyne, Griffin, Isabel, Nahabedian, John, Newton, Suzanne, Roth, Nicole M., Shinde, Neha, Whitehouse, Erin, Chang, Daniel, Fox, Charise, Mohamoud, Yousra, and Whitehill, Florence

Subjects
Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, Abortion, 01 natural sciences, 0302 clinical medicine, COVID-19 Testing, Health Information Management, Pregnancy, Infection control, 030212 general & internal medicine, Full Report, Young adult, Pregnancy Complications, Infectious, education.field_of_study, Obstetrics, Pregnancy Outcome, Gestational age, General Medicine, Premature birth, Premature Birth, Female, Coronavirus Infections, Adult, medicine.medical_specialty, Population, Pneumonia, Viral, Risk Assessment, 03 medical and health sciences, Betacoronavirus, Young Adult, medicine, Humans, 0101 mathematics, education, Pandemics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, Public health, 010102 general mathematics, Infant, Newborn, COVID-19, medicine.disease, Infectious Disease Transmission, Vertical, United States, Abortion, Spontaneous, business, Laboratories
Abstract

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (

Published
2020

35. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

Author

Zambrano, Laura D., Ellington, Sascha, Strid, Penelope, Galang, Romeo R., Oduyebo, Titilope, Tong, Van T., Woodworth, Kate R., Nahabedian, John F., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Meaney-Delman, Dana, Akosa, Amanda, Bennett, Carolyne, Burkel, Veronica, Chang, Daniel, Delaney, Augustina, Fox, Charise, Griffin, Isabel, Hsia, Jason, Krause, Katie, Lewis, Elizabeth, Manning, Susan, Mohamoud, Yousra, Newton, Suzanne, Neelam, Varsha, Olsen, Emily O’Malley, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Roth, Nicole M., Sancken, Christina, Shinde, Neha, Smoots, Ashley, Snead, Margaret, Wallace, Bailey, Whitehill, Florence, Whitehouse, Erin, and Zapata, Lauren

Subjects
Adult, medicine.medical_specialty, Health (social science), Adolescent, Epidemiology, Health, Toxicology and Mutagenesis, medicine.medical_treatment, Pneumonia, Viral, Prenatal care, 01 natural sciences, Risk Assessment, Severity of Illness Index, law.invention, 03 medical and health sciences, Betacoronavirus, Young Adult, 0302 clinical medicine, COVID-19 Testing, Health Information Management, law, Pregnancy, Severity of illness, Extracorporeal membrane oxygenation, medicine, Humans, 030212 general & internal medicine, Full Report, 0101 mathematics, Young adult, Pregnancy Complications, Infectious, Pandemics, Obstetrics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, 010102 general mathematics, COVID-19, General Medicine, medicine.disease, Intensive care unit, United States, Relative risk, Female, Symptom Assessment, Risk assessment, business, Coronavirus Infections, Laboratories
Abstract

Studies suggest that pregnant women might be at increased risk for severe illness associated with coronavirus disease 2019 (COVID-19) (1,2). This report provides updated information about symptomatic women of reproductive age (15-44 years) with laboratory-confirmed infection with SARS-CoV-2, the virus that causes COVID-19. During January 22-October 3, CDC received reports through national COVID-19 case surveillance or through the National Notifiable Diseases Surveillance System (NNDSS) of 1,300,938 women aged 15-44 years with laboratory results indicative of acute infection with SARS-CoV-2. Data on pregnancy status were available for 461,825 (35.5%) women with laboratory-confirmed infection, 409,462 (88.7%) of whom were symptomatic. Among symptomatic women, 23,434 (5.7%) were reported to be pregnant. After adjusting for age, race/ethnicity, and underlying medical conditions, pregnant women were significantly more likely than were nonpregnant women to be admitted to an intensive care unit (ICU) (10.5 versus 3.9 per 1,000 cases; adjusted risk ratio [aRR] = 3.0; 95% confidence interval [CI] = 2.6-3.4), receive invasive ventilation (2.9 versus 1.1 per 1,000 cases; aRR = 2.9; 95% CI = 2.2-3.8), receive extracorporeal membrane oxygenation (ECMO) (0.7 versus 0.3 per 1,000 cases; aRR = 2.4; 95% CI = 1.5-4.0), and die (1.5 versus 1.2 per 1,000 cases; aRR = 1.7; 95% CI = 1.2-2.4). Stratifying these analyses by age and race/ethnicity highlighted disparities in risk by subgroup. Although the absolute risks for severe outcomes for women were low, pregnant women were at increased risk for severe COVID-19-associated illness. To reduce the risk for severe illness and death from COVID-19, pregnant women should be counseled about the importance of seeking prompt medical care if they have symptoms and measures to prevent SARS-CoV-2 infection should be strongly emphasized for pregnant women and their families during all medical encounters, including prenatal care visits. Understanding COVID-19-associated risks among pregnant women is important for prevention counseling and clinical care and treatment.

Published
2020

36. Influenza and Tetanus, Diphtheria, and Acellular Pertussis Vaccination During Pregnancy, Pregnancy Risk Assessment Monitoring System, 2019

Author

Oduyebo, Titilope, primary, Kortsmit, Katie, additional, Simeone, Regina, additional, Kahn, Katherine, additional, Razzaghi, Hilda, additional, Galang, Romeo, additional, Ellington, Sascha, additional, Ruffo, Nan, additional, Barfield, Wanda, additional, Warner, Lee, additional, and Cox, Shanna, additional

Published
2022
Full Text
View/download PDF

37. Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons

Author

Shimabukuro, Tom T., primary, Kim, Shin Y., additional, Myers, Tanya R., additional, Moro, Pedro L., additional, Oduyebo, Titilope, additional, Panagiotakopoulos, Lakshmi, additional, Marquez, Paige L., additional, Olson, Christine K., additional, Liu, Ruiling, additional, Chang, Karen T., additional, Ellington, Sascha R., additional, Burkel, Veronica K., additional, Smoots, Ashley N., additional, Green, Caitlin J., additional, Licata, Charles, additional, Zhang, Bicheng C., additional, Alimchandani, Meghna, additional, Mba-Jonas, Adamma, additional, Martin, Stacey W., additional, Gee, Julianne M., additional, and Meaney-Delman, Dana M., additional

Published
2021
Full Text
View/download PDF

38. Prolonged Detection of Zika Virus RNA in Pregnant Women

Author

Meaney-Delman, Dana, Oduyebo, Titilope, Polen, Kara N.D., White, Jennifer L., Bingham, Andrea M., Slavinski, Sally A., Heberlein-Larson, Lea, St. George, Kirsten, Rakeman, Jennifer L., Hills, Susan, Olson, Christine K., Adamski, Alys, Culver Barlow, Lauren, Lee, Ellen H., Likos, Anna M., Muñoz, Jorge L., Petersen, Emily E., Dufort, Elizabeth M., Dean, Amy B., Cortese, Margaret M., Santiago, Gilberto A., Bhatnagar, Julu, Powers, Ann M., Zaki, Sherif, Petersen, Lyle R., Jamieson, Denise J., and Honein, Margaret A.

Published
2016
Full Text
View/download PDF

42. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion

Author

Zauche, Lauren H., primary, Wallace, Bailey, additional, Smoots, Ashley N., additional, Olson, Christine K., additional, Oduyebo, Titilope, additional, Kim, Shin Y., additional, Petersen, Emily E., additional, Ju, Jun, additional, Beauregard, Jennifer, additional, Wilcox, Allen J., additional, Rose, Charles E., additional, Meaney-Delman, Dana M., additional, and Ellington, Sascha R., additional

Published
2021
Full Text
View/download PDF

43. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021

Author

Galang, Romeo R, Newton, Suzanne M, Woodworth, Kate R, Griffin, Isabel, Oduyebo, Titilope, Sancken, Christina L, Olsen, Emily O'Malley, Aveni, Kathryn, Wingate, Heather, Shephard, Hanna, Fussman, Chris, Alaali, Zahra S, Silcox, Kristin, Siebman, Samantha, Halai, Umme-Aiman, Lopez, Camille Delgado, Lush, Mamie, Sokale, Ayomide, Barton, Jerusha, Chaudhary, Ifrah, Patrick, Paul H, Schlosser, Levi, Reynolds, Bethany, Gaarenstroom, Nicole, Chicchelly, Sarah, Read, Jennifer S, de Wilde, Leah, Mbotha, Deborah, Azziz-Baumgartner, Eduardo, Hall, Aron J, Tong, Van T, Ellington, Sascha, and Gilboa, Suzanne M

Subjects
Adult, SARS-CoV-2, COVID-19, Mothers, macromolecular substances, AcademicSubjects/MED00290, illness severity, Pregnancy, Risk Factors, Humans, Supplement Article, Female, Pregnant Women, Pregnancy Complications, Infectious, Aged
Abstract

Background Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with SARS-CoV-2 infection. Methods Pregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during March 29, 2020–March 5, 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics. Results Among 7,950 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 25 years and older, healthcare occupation, pre-pregnancy obesity, chronic lung disease, chronic hypertension, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions. Conclusions Older age and having underlying medical conditions were associated with increased risk of moderate-to-severe or critical COVID-19 illness among pregnant women. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and inform targeted public health messaging.

Published
2021

44. Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21

Author

Zauche, Lauren Head, primary, Wallace, Bailey, additional, Smoots, Ashley N., additional, Olson, Christine K., additional, Oduyebo, Titilope, additional, Kim, Shin Y., additional, Peterson, Emily E., additional, Ju, Jun, additional, Beauregard, Jennifer, additional, Wilcox, Allen J., additional, Rose, Charles E., additional, Meaney-Delman, Dana, additional, and Ellington, Sascha R., additional

Published
2021
Full Text
View/download PDF

45. Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis

Author

Ko, Jean Y, primary, DeSisto, Carla L, additional, Simeone, Regina M, additional, Ellington, Sascha, additional, Galang, Romeo R, additional, Oduyebo, Titilope, additional, Gilboa, Suzanne M, additional, Lavery, Amy M, additional, Gundlapalli, Adi V, additional, and Shapiro-Mendoza, Carrie K, additional

Published
2021
Full Text
View/download PDF

46. Real-Time CDC Consultation during the COVID-19 Pandemic—United States, March–July, 2020

Author

Wozniczka, Daniel, primary, Demeke, Hanna B., additional, Thompson-Paul, Angela M., additional, Ijeoma, Ugonna, additional, Williams, Tonya R., additional, Taylor, Allan W., additional, Tan, Kathrine R., additional, Chevalier, Michelle S., additional, Agyemang, Elfriede, additional, Dowell, Deborah, additional, Oduyebo, Titilope, additional, Shiferaw, Miriam, additional, Coleman King, Sallyann M., additional, Minta, Anna A., additional, Shealy, Katherine, additional, Oliver, Sara E., additional, McLean, Catherine, additional, Glover, Maleeka, additional, and Iskander, John, additional

Published
2021
Full Text
View/download PDF

48. Plague During Pregnancy: A Systematic Review

Author

Fleck-Derderian, Shannon, primary, Nelson, Christina A, primary, Cooley, Katharine M, primary, Russell, Zachary, primary, Godfred-Cato, Shana, primary, Oussayef, Nadia L, primary, Oduyebo, Titilope, primary, Rasmussen, Sonja A, primary, Jamieson, Denise J, primary, and Meaney-Delman, Dana, primary

Published
2020
Full Text
View/download PDF

49. Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection—Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020–5 March 2021

Author

Galang, Romeo R, Newton, Suzanne M, Woodworth, Kate R, Griffin, Isabel, Oduyebo, Titilope, Sancken, Christina L, Olsen, Emily O'Malley, Aveni, Kathryn, Wingate, Heather, Shephard, Hanna, Fussman, Chris, Alaali, Zahra S, Silcox, Kristin, Siebman, Samantha, Halai, Umme-Aiman, Lopez, Camille Delgado, Lush, Mamie, Sokale, Ayomide, Barton, Jerusha, and Chaudhary, Ifrah

Subjects
PUBLIC health surveillance, COVID-19, CONFIDENCE intervals, SEVERITY of illness index, RISK assessment, DESCRIPTIVE statistics, DATA analysis software, WOMEN'S health, EVALUATION, PREGNANCY
Abstract

Background Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Methods Pregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during 29 March 2020–5 March 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics. Results Among 7950 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 25 years and older, healthcare occupation, prepregnancy obesity, chronic lung disease, chronic hypertension, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions. Conclusions Older age and having underlying medical conditions were associated with increased risk of moderate-to-severe or critical COVID-19 illness among pregnant women. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and can inform targeted public health messaging. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results